Global Hepatitis C Clinical Trials Market Review H2 2014 Report at ReportsnReports.com
Dallas, TX (PRWEB) December 03, 2014 -- The clinical trial report "Hepatitis C Global Clinical Trials Review H2 2014" provides data on the Hepatitis C clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis C. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis C. Complete Report Available @ http://www.reportsnreports.com/reports/319733-hepatitis-c-global-clinical-trials-review-h2-2014.html .
The hepatitis C virus is one of the many causes of inflammation of the liver. The report “Hepatitis C Global Clinical Trials Review H2 2014” discuss the Clinical Trial Overview of Top Companies include Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., Bristol-Myers Squibb Company, Vertex Pharmaceuticals Incorporated, Johnson & Johnson, C. H. Boehringer Sohn AG & Co. KG, AbbVie Inc, Novartis AG, GlaxoSmithKline plc. Order a Purchase copy @ http://www.reportsnreports.com/Purchase.aspx?name=319733 .
Scope
• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons To Buy
• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Inquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=319733 . (This is a premium report priced at US$2500 for a single user License.)
Major Points in Table of Content
List of Tables
Hepatitis C Therapeutics, Global, Clinical Trials by Region, 2014
Hepatitis C Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Hepatitis C Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Hepatitis C Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014
Hepatitis C Therapeutics Clinical Trials, Europe, Top Five Countries, 2014
Hepatitis C Therapeutics Clinical Trials, North America, Top Countries, 2014
Hepatitis C Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014
Hepatitis C Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014
Proportion of Hepatitis C to Infectious Disease Clinical Trials, G7 Countries (%), 2014
Hepatitis C Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Hepatitis C Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Hepatitis C to Infectious Disease Clinical Trials, E7 Countries (%), 2014
Hepatitis C Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Hepatitis C Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014
Hepatitis C Therapeutics, Global, Clinical Trials by Phase, 2014
Hepatitis C Therapeutics, Global, Clinical Trials In Progress by Phase 2014
Hepatitis C Therapeutics, Global, Clinical Trials by Trial Status, 2014
Hepatitis C Therapeutics Clinical Trials, Global, by End Point Status, 2014
Hepatitis C Therapeutics, Global, Suspended Clinical Trials, 2014
Hepatitis C Therapeutics, Global, Withdrawn Clinical Trials, 2014
Hepatitis C Therapeutics, Global, Terminated Clinical Trials, 2014
Hepatitis C Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Hepatitis C Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014
Hepatitis C Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Hepatitis C Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Hepatitis C Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Vertex Pharmaceuticals Incorporated, 2014
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014
Explore more reports on Pharmaceuticals industry at http://www.reportsnreports.com/market-research/pharmaceuticals/ .
About Us:
ReportsnReports.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Ritesh Tiwari, ReportsnReports, http://www.reportsnreports.com/, +1 (888) 391-5441, [email protected]
Share this article